These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8834646)
1. [Reactivity to hepatitis B vaccination (HBV) in patients with uremia: association with defined HLA antigen configuration and complement protein allotypes C4A, C4B and B factor (Bf)]. Stachowski J; Runowski D; Kramer J; Madaliński K; Maciejewski J; Baldamus CA Przegl Lek; 1995; 52(9):445-54. PubMed ID: 8834646 [TBL] [Abstract][Full Text] [Related]
2. Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II and III alleles in haemodialysis patients. Stachowski J; Kramer J; Füst G; Maciejewski J; Baldamus CA; Petrányi GG Scand J Immunol; 1995 Jul; 42(1):60-5. PubMed ID: 7631146 [TBL] [Abstract][Full Text] [Related]
3. Genetic regulation of the impaired immune response to hepatitis-B vaccine associated with low TCR density in end stage renal disease patients: contribution of complement C4 and factor B alleles. Kramer J; Stachowski J; Barth C; Ujhelyi E; Tarján V; Sulowicz W; Füst G; Baldamus CA Immunol Lett; 1997 Oct; 59(1):13-9. PubMed ID: 9334852 [TBL] [Abstract][Full Text] [Related]
4. Investigation of allotypes of HLA class III (C2, BF and C4) in patients with schizophrenia. Wang C; Jian BX; Jiang XD; Zhao XZ Chin Med J (Engl); 1992 Apr; 105(4):316-8. PubMed ID: 1618015 [TBL] [Abstract][Full Text] [Related]
5. [Changes in the polymorphism and concentrations of components of the class II complement after orthotopic transplantation of the liver]. Uring-Lambert B; Valette C; Hartmann D; Wolf P; Hauptmann G Gastroenterol Clin Biol; 1995 Dec; 19(12):976-9. PubMed ID: 8729408 [TBL] [Abstract][Full Text] [Related]
6. Allotyping human complement factor B in Asian Indian type 1 diabetic patients. Kumar N; Kaur G; Tandon N; Mehra NK Tissue Antigens; 2008 Dec; 72(6):517-24. PubMed ID: 19000152 [TBL] [Abstract][Full Text] [Related]
7. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Wiedmann M; Liebert UG; Oesen U; Porst H; Wiese M; Schroeder S; Halm U; Mössner J; Berr F Hepatology; 2000 Jan; 31(1):230-4. PubMed ID: 10613751 [TBL] [Abstract][Full Text] [Related]
8. [Complement markers Bf and C4 in multiple sclerosis]. Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572 [TBL] [Abstract][Full Text] [Related]
9. Autoimmune-associated HLA-B8-DR3 haplotypes in Asian Indians are unique in C4 complement gene copy numbers and HSP-2 1267A/G. Kaur G; Kumar N; Szilagyi A; Blasko B; Fust G; Rajczy K; Pozsonyi E; Hosso A; Petranyi G; Tandon N; Mehra N Hum Immunol; 2008 Sep; 69(9):580-7. PubMed ID: 18657583 [TBL] [Abstract][Full Text] [Related]
10. Influence of genetic factors on the susceptibility to HBV infection, its clinical pictures, and responsiveness to HBV vaccination. Kacprzak-Bergman I; Nowakowska B Arch Immunol Ther Exp (Warsz); 2005; 53(2):139-42. PubMed ID: 15928582 [TBL] [Abstract][Full Text] [Related]
11. Interactive effect of Gm allotypes and HLA-B locus antigens on the human antibody response to a bacterial antigen. Whittingham S; Mathews JD; Schanfield MS; Matthews JV; Tait BD; Morris PJ; Mackay IR Clin Exp Immunol; 1980 Apr; 40(1):8-15. PubMed ID: 6930337 [TBL] [Abstract][Full Text] [Related]
12. The importance of A3 allele in response to hepatitis B vaccine in end-stage renal disease patients. Ozdemir FN; Micozkadioglu H; Arat Z; Turan M; Gulmus S; Haberal M Transplant Proc; 2004 Nov; 36(9):2615-7. PubMed ID: 15621103 [TBL] [Abstract][Full Text] [Related]
13. Improved immunogenicity of a novel third-generation recombinant hepatitis B vaccine in patients with end-stage renal disease. Weinstein T; Chagnac A; Boaz M; Ori Y; Herman M; Zevin D; Schmilovitz-Weiss H; Gafter U Nephron Clin Pract; 2004; 97(2):c67-72. PubMed ID: 15218332 [TBL] [Abstract][Full Text] [Related]
14. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells. Krishnamurthy G; Kher V; Naik S Scand J Urol Nephrol; 2002; 36(5):377-82. PubMed ID: 12487744 [TBL] [Abstract][Full Text] [Related]
15. Bf and C4 phenotypes in patients with psoriasis. Wyatt RJ; Wang C; Hudson EC; Jones RM; Noah PW; Rosenberg EW Acta Derm Venereol Suppl (Stockh); 1989; 146():211-3. PubMed ID: 2609873 [TBL] [Abstract][Full Text] [Related]
16. Association of HLA phenotype with primary non-response to recombinant hepatitis B vaccine: a study from north India. Das K; Gupta RK; Kumar V; Singh S; Kar P Trop Gastroenterol; 2004; 25(3):113-5. PubMed ID: 15682656 [TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex class I to III allotypes in patients with AIDS-related complex/Walter-Reed 5, disseminated Kaposi's sarcoma and in normal controls. The ARC-IVIG Study Group. Plum G; Siebel E; Bendick C; Rasokat H; Braun M; Krickeberg H; Mauff G Vox Sang; 1990; 59 Suppl 1():15-20. PubMed ID: 2238573 [TBL] [Abstract][Full Text] [Related]
18. HLA-B27 and allotypes of complement components in ankylosing spondylitis. Gran JT; Teisberg P; Olaissen B; Thorsby E; Husby G J Rheumatol; 1984 Jun; 11(3):324-6. PubMed ID: 6610755 [TBL] [Abstract][Full Text] [Related]
19. [Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters]. Grosse-Wilde H; Toyka KV; Besinger UA; Doxiadis I; Heininger K; Hömberg M; Hömberg V; Hohlfeld R; Fateh-Moghadam A; Jungwirth J; Kreeb G; Vögeler U Dtsch Med Wochenschr; 1983 May; 108(18):694-700. PubMed ID: 6839994 [TBL] [Abstract][Full Text] [Related]
20. Complement factor B allotypes in the susceptibility and severity of coeliac disease in patients and relatives. da Rosa Utiyama SR; da Silva Kotze LM; de Messias Reason IT Int J Immunogenet; 2005 Oct; 32(5):307-14. PubMed ID: 16164698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]